Anthony S. Marucci

CIK: 0001429933

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CLDX

Celldex Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CLDX
Celldex Therapeutics, Inc.
Jun 25, 2026
Award(A)
Incentive Stock Option (right to buy)
Direct
375K shares-
CLDX
Celldex Therapeutics, Inc.
Jun 5, 2025
Award(A)
Incentive Stock Option (right to buy)
Direct
300K shares-
CLDX
Celldex Therapeutics, Inc.
Nov 11, 2024
Purchase(P)
Direct
11.5K shares at avg. $26.82$308K

		Type	Shares	Price		Ownership
Jun 25, 2026	CLDX Celldex Therapeutics, Inc.	Award(A) Incentive Stock Option (right to buy)	375,000	-	-	Direct
Jun 5, 2025	CLDX Celldex Therapeutics, Inc.	Award(A) Incentive Stock Option (right to buy)	300,000	-	-	Direct
Nov 11, 2024	CLDX Celldex Therapeutics, Inc.	Purchase(P)	11,500	$26.82	$308,430	Direct

1-3 of 3 transactions

About Marucci Anthony S

Marucci Anthony S (SEC CIK 0001429933) files insider reports with the SEC as PRESIDENT & CEO of Celldex Therapeutics, Inc. (CLDX).

Signal8 holds 3 ownership filings by Marucci Anthony S, all Form 4s, filed between Nov 12, 2024 and Jun 29, 2026. Those filings report 3 transactions, from Nov 11, 2024 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Marucci Anthony S's filings is in HAMPTON, NJ.

Recent filings by Marucci Anthony S

Jun 25, 2026: Grant or award of CLDX derivative securities (Form 4, code A).
Jun 5, 2025: Grant or award of CLDX derivative securities (Form 4, code A).
Nov 11, 2024: Open-market purchase of CLDX shares (Form 4, code P).

Other insiders filing for Celldex Therapeutics, Inc. (CLDX)

Lawver Teri L, SVP & Chief Commercial Officer
Jimenez Freddy A., SVP & GENERAL COUNSEL
Young Diane C., SVP, CHIEF MEDICAL OFFICER
Heath-Chiozzi Margo, SVP OF REGULATORY AFFAIRS
Martin Samuel Bates, SVP AND CFO
Cavanaugh Sarah, SVP OF CORP AFFAIRS & ADMIN.

How to read Form 4 transaction codes